Dyslipidemia and high waist-hip ratio in women with self-reported social anxiety

Psychoneuroendocrinology

Volumn 29, Issue 8, 2004, Pages 1037-1046

  Landén, Mikael ^a   Baghaei, Fariba ^b   Rosmond, Roland ^b   Holm, Göran ^b   Björntorp, Per ^b   Eriksson, Elias ^b  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Anthropometry; Lipids; Metabolic syndrome X; Phobic disorders

Indexed keywords

HIGH DENSITY LIPOPROTEIN; HORMONE; LIPID; LOW DENSITY LIPOPROTEIN; TESTOSTERONE; THYROXINE; TRIACYLGLYCEROL;

ADULT; ANTHROPOMETRY; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; DYSLIPIDEMIA; FEMALE; HIP; HORMONE BLOOD LEVEL; HUMAN; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; POPULATION; PREVALENCE; PRIORITY JOURNAL; PSYCHIATRIC DIAGNOSIS; QUESTIONNAIRE; SELF REPORT; SOCIAL PHOBIA; TESTOSTERONE BLOOD LEVEL; THYROXINE BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; ANXIETY DISORDERS; BODY CONSTITUTION; BODY MASS INDEX; COHORT STUDIES; COMORBIDITY; FEMALE; HUMANS; HYPERLIPIDEMIAS; LIPOPROTEINS; SELF ASSESSMENT (PSYCHOLOGY); SOCIAL ENVIRONMENT; SWEDEN; TESTOSTERONE; THYROXINE; TRIGLYCERIDES;

EID: 3042547389     PISSN: 03064530     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2003.10.006     Document Type: Article

References (68)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. fourth ed. 1994;APA, Washington, DC
2. Andersson B., Mårin P., Lissner L., Vermeulen A., Björntorp P. Testosterone concentrations in women and men with NIDDM. Diabetes Care. 17:1994;405-411
3. Arlt W., Callies F., van Vlijmen J.C., Koehler I., Reincke M., Bidlingmaier M., Huebler D., Oettel M., Ernst M., Schulte H.M., Allolio B. Dehydroepiandrosterone replacement in women with adrenal insufficiency. N. Engl. J. Med. 341:1999;1013-1020
4. Austin M.A., Goto Y., Lenfant C., Tyroler H.A. The hypertriglyceridemias: risk and management. Epidemiol. Am. J. Cardiol. 68:1991;22A-25A
5. Björntorp P. Endocrine abnormalities of obesity. Metabolism. 44:1995;21-23
6. Björntorp P. The android woman - a risky condition. J. Intern. Med. 239:1996;105-110
7. Bowen D.J., Kestin M., McTiernan A., Carrell D., Green P. Effects of dietary fat intervention on mental health in women. Cancer Epidemiol. Biomarkers. Prev. 4:1995;555-559
8. Brunello N., den Boer J.A., Judd L.L., Kasper S., Kelsey J.E., Lader M., Lecrubier Y., Lepine J.P., Lydiard R.B., Mendlewicz J., Montgomery S.A., Racagni G., Stein M.B., Wittchen H. Social phobia: diagnosis and epidemiology, neurobiology and pharmacology, comorbidity and treatment. J. Affect. Disord. 60:2000;61-74
9. Chen C.C., Lu F.H., Wu J.S., Chang C.J. Correlation between serum lipid concentrations and psychological distress. Psychiatry Res. 102:2001;153-162
10. Condren R.M., O'Neill A., Ryan M.C., Barrett P., Thakore J.H. HPA axis response to a psychological stressor in generalised social phobia. Psychoneuroendocrinology. 27:2002;693-703
11. Cullen P. Evidence that triglycerides are an independent coronary heart disease risk factor. Am. J. Cardiol. 86:2000;943-949
12. Curtin F., Schulz P. Multiple correlations and Bonferroni's correction. Biol. Psychiatry. 44:1998;775-777
13. Davidson K.W., Reddy S., McGrath P., Zitner D., MacKeen W. Increases in depression after cholesterol-lowering drug treatment. Behav. Med. 22:1996;82-84
14. Davis S. Testosterone deficiency in women. J. Reprod. Med. 46:2001;291-296
15. Efstathiadou Z., Bitsis S., Milionis H.J., Kukuvitis A., Bairaktari E.T., Elisaf M.S., Tsatsoulis A. Lipid profile in subclinical hypothyroidism: is L-thyroxine substitution beneficial? Eur. J. Endocrinol. 145:2001;705-710
16. Ehlert U., Gaab J., Heinrichs M. Psychoneuroendocrinological contributions to the etiology of depression posttraumatic stress disorder, and stress-related bodily disorders: the role of the hypothalamus-pituitary-adrenal axis. Biol. Psychol. 57:2001;141-152
17. Epel E.S., McEwen B., Seeman T., Matthews K., Castellazzo G., Brownell K.D., Bell J., Ickovics J.R. Stress and body shape: stress-induced cortisol secretion is consistently greater among women with central fat. Psychosom. Med. 62:2000;623-632
18. Fleet R., Lavoie K., Beitman B.D. Is panic disorder associated with coronary artery disease? A critical review of the literature. J. Psychosom. Res. 48:2000;347-356
19. Gallerani M., Manfredini R., Caracciolo S., Scapoli C., Molinari S., Fersini C. Serum cholesterol concentrations in parasuicide. Br. Med. J. 310:1995;1632-1636
20. Gorman J.M., Sloan R.P. Heart rate variability in depressive and anxiety disorders. Am. Heart J. 140:2000;77-83
21. Gotto A.M. Jr. Triglyceride as a risk factor for coronary artery disease. Am. J. Cardiol. 82:1998;22Q-25Q
22. Haines A.P., Imeson J.D., Meade T.W. Phobic anxiety and ischaemic heart disease. Br. Med. J. (Clin. Res. Ed.). 295:1987;297-299
23. Haines A., Cooper J., Meade T.W. Psychological characteristics and fatal ischaemic heart disease. Heart. 85:2001;385-389
24. Hällström T. Point prevalence of major depressive disorder in a Swedish urban female population. Acta Psychiatr. Scand. 69:1984;52-59
25. Joynt K.E., Whellan D.J., O'Connor C.M. Depression and cardiovascular disease: mechanisms of interaction. Biol. Psychiatry. 54:2003;248-261
26. Kawachi I., Colditz G.A., Ascherio A., Rimm E.B., Giovannucci E., Stampfer M.J., Willett W.C. Prospective study of phobic anxiety and risk of coronary heart disease in men. Circulation. 89:1994a;1992-1997
27. Kawachi I., Sparrow D., Vokonas P.S., Weiss S.T. Symptoms of anxiety and risk of coronary heart disease. The normative aging study. Circulation. 90:1994b;2225-2229
28. Kaye S.A., Folsom A.R., Jacobs D.R. Jr., Hughes G.H., Flack J.M. Psychosocial correlates of body fat distribution in black and white young adults. Int. J. Obes. Relat. Metab. Disord. 17:1993;271-277
29. Kessler, R.C. 2003. The impairments caused by social phobia in the general population: implications for intervention. Acta Psychiatr. Scand. Suppl. 19-27.
30. Kessler R.C., McGonagle K.A., Zhao S., Nelson C.B., Hughes M., Eshleman S., Wittchen H.U., Kendler K.S. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the national comorbidity survey. Arch. Gen. Psychiatry. 51:1994;8-19
31. Kessler R.C., Stein M.B., Berglund P. Social phobia subtypes in the national comorbidity survey. Am. J. Psychiatry. 155:1998a;613-619
32. Kessler R.C., Walters E.E., Forthofer M.S. The social consequences of psychiatric disorders, III: probability of marital stability. Am. J. Psychiatry. 155:1998b;1092-1096
33. LaRosa J.C. Triglycerides and coronary risk in women and the elderly. Arch. Intern. Med. 157:1997;961-968
34. Law M.R., Thompson S.G., Wald N.J. Assessing possible hazards of reducing serum cholesterol. Br. Med. J. 308:1994;373-379
35. Lecrubier Y. Comorbidity in social anxiety disorder: impact on disease burden and management. J. Clin. Psychiatry. 59:1998;33-38
36. Ljung T., Andersson B., Bengtsson B.A., Bjorntorp P., Marin P. Inhibition of cortisol secretion by dexamethasone in relation to body fat distribution: a dose-response study. Obes. Res. 4:1996;277-282
37. Lloyd C.E., Wing R.R., Orchard T.J. Waist to hip ratio and psychosocial factors in adults with insulin-dependent diabetes mellitus: the Pittsburgh epidemiology of diabetes complications study. Metabolism. 45:1996;268-272
38. Mårin P., Darin N., Amemiya T., Andersson B., Jern S., Björntorp P. Cortisol secretion in relation to body fat distribution in obese premenopausal women. Metabolism. 41:1992;882-886
39. Martel F.L., Hayward C., Lyons D.M., Sanborn K., Varady S., Schatzberg A.F. Salivary cortisol levels in socially phobic adolescent girls. Depress. Anxiety. 10:1999;25-27
40. Mendlowicz M.V., Stein M.B. Quality of life in individuals with anxiety disorders. Am. J. Psychiatry. 157:2000;669-682
41. Muldoon M.F., Manuck S.B., Matthews K.A. Lowering cholesterol concentrations and mortality: a quantitative review of primary prevention trials. Br. Med. J. 301:1990;309-314
42. Musselman D.L., Evans D.L., Nemeroff C.B. The relationship of depression to cardiovascular disease: epidemiology, biology, and treatment. Arch. Gen. Psychiatry. 55:1998;580-592
43. Pariante C.M. Depression, stress and the adrenal axis. J. Neuroendocrinol. 15:2003;811-812
44. Partonen T., Haukka J., Virtamo J., Taylor P.R., Lonnqvist J. Association of low serum total cholesterol with major depression and suicide. Br.J. Psychiatry. 175:1999;259-262
45. Pelissolo A., Andre C., Moutard-Martin F., Wittchen H.U., Lepine J.P. Social phobia in the community: relationship between diagnostic threshold and prevalence. Eur. Psychiatry. 15:2000;25-28
46. Penninx B.W., Beekman A.T., Honig A., Deeg D.J., Schoevers R.A., van Eijk J.T., van Tilburg W. Depression and cardiac mortality: results from a community-based longitudinal study. Arch. Gen. Psychiatry. 58:2001;221-227
47. Pereira M.A., Schreiner P.J., Pankow J.S., Williams R.R., Higgins M., Province M.A., Rao D.C. The family risk score for coronary heart disease: associations with lipids, lipoproteins, and body habitus in a middle-aged bi-racial cohort: the ARIC study. Ann. Epidemiol. 10:2000;239-245
48. Perneger T.V. What's wrong with Bonferroni adjustments. Br. Med. J. 316:1998;1236-1238
49. Pucci E., Chiovato L., Pinchera A. Thyroid and lipid metabolism. Int. J. Obes. Relat. Metab. Disord. 24:(Suppl. 2):2000;S109-S112
50. Raikkonen K., Matthews K.A., Kuller L.H. Anthropometric and psychosocial determinants of visceral obesity in healthy postmenopausal women. Int. J. Obes. Relat. Metab. Disord. 23:1999;775-782
51. Rosmond R., Björntorp P. Psychiatric ill-health of women and its relationship to obesity and body fat distribution. Obes. Res. 6:1998;338-345
52. Rosmond R., Nilsson A., Björntorp P. Psychiatric ill health and distribution of body fat mass among female immigrants in Sweden. Public Health. 114:2000;45-51
53. Rudisch B., Nemeroff C.B. Epidemiology of comorbid coronary artery disease and depression. Biol. Psychiatry. 54:2003;227-240
54. Schneier F.R., Johnson J., Hornig C.D., Liebowitz M.R., Weissman M.M. Social phobia. Comorbidity and morbidity in an epidemiologic sample. Arch. Gen. Psychiatry. 49:1992;282-288
55. Schwertner H.A., Fischer J.R. Jr. Comparison of various lipid, lipoprotein, and bilirubin combinations as risk factors for predicting coronary artery disease. Atherosclerosis. 150:2000;381-387
56. Seidell J.C., Cigolini M., Charzewska J., Ellsinger B.M., Di Biase G., Björntorp P., Hautvast J.G., Contaldo F., Szostak V., Scuro L.A. Androgenicity in relation to body fat distribution and metabolism in 38-year-old women - the European fat distribution study. J. Clin. Epidemiol. 43:1990;21-34
57. Strowitzki T., Halser B., Demant T. Body fat distribution, insulin sensitivity, ovarian dysfunction and serum lipoproteins in patients with polycystic ovary syndrome. Gynecol. Endocrinol. 16:2002;45-51
58. Tancer M.E., Stein M.B., Gelernter C.S., Uhde T.W. The hypothalamic-pituitary-hyroid axis in social phobia. Am. J. Psychiatry. 147:1990;929-933
59. Tunbridge W.M., Evered D.C., Hall R., Appleton D., Brewis M., Clark F., Evans J.G., Young E., Bird T., Smith P.A. Lipid profiles and cardiovascular disease in the Whickham area with particular reference to thyroid failure. Clin. Endocrinol. (Oxford). 7:1977;495-508
60. Uhde T.W., Tancer M.E., Gelernter C.S., Vittone B.J. Normal urinary free cortisol and postdexamethasone cortisol in social phobia: comparison to normal volunteers. J. Affect. Disord. 30:1994;155-161
61. Wardle J., Armitage J., Collins R., Wallendszus K., Keech A., Lawson A. Randomised placebo controlled trial of effect on mood of lowering cholesterol concentration. Oxford Cholesterol Study Group. Br. Med. J. 313:1996;75-78
62. Wardle J., Rogers P., Judd P., Taylor M.A., Rapoport L., Green M., Nicholson Perry K. Randomized trial of the effects of cholesterol-lowering dietary treatment on psychological function. Am. J. Med. 108:2000;547-553
63. Weidner G., Connor S.L., Hollis J.F., Connor W.E. Improvements in hostility and depression in relation to dietary change and cholesterol lowering. The family heart study. Ann. Intern. Med. 117:1992;820-823
64. Weiller E., Bisserbe J.C., Boyer P., Lepine J.P., Lecrubier Y. Social phobia in general health care: an unrecognised undertreated disabling disorder. Br. J. Psychiatry. 168:1996;169-174
65. Wells A.S., Read N.W., Laugharne J.D., Ahluwalia N.S. Alterations in mood after changing to a low-fat diet. Br. J. Nutr. 79:1998;23-30
66. Wiklund O., Fager G., Craig I.H., Wilhelmsson C.E., Vedin A., Olofsson S.O., Bondjers G., Wilhelmsen L. Alphalipoprotein cholesterol levels in relation to acute myocardial infarction and its risk factors. Scand. J. Clin. Lab. Invest. 40:1980;239-247
67. Wing R.R., Matthews K.A., Kuller L.H., Meilahn E.N., Plantinga P. Waist to hip ratio in middle-aged women. Associations with behavioral and psychosocial factors and with changes in cardiovascular risk factors. Arterioscler. Thromb. 11:1991;1250-1257
68. Zaubler T.S., Katon W. Panic disorder and medical comorbidity: a review of the medical and psychiatric literature. Bull. Menninger Clin. 60:1996;A12-A38